Registered Interests
Registered Interests for Lord Kakkar.
Category 1: Remunerated employment etc.
- Practising clinician (interest ceased 10 April 2025)
- Scientific Adviser/honoraria in the field of thrombosis research to Bayer Healthcare (interest ceased 31 January 2025), Sanofi (interest ceased 31 January 2025), Anthos Therapeutics and VarmX
- Non-executive Director, Howard de Walden Estate and Howard de Walden Holdings
- Director, Cyte Ltd (clinical research)
- Chairman, King's Health Partners (Guy’s and St Thomas’s NHS Foundation Trust)
- President, Thrombosis Research Institute
- Scientific Adviser, ALJ Health (global distributor of healthcare innovations)
Category 2: Shareholdings etc. (b)
- Tenac.io GmbH (cardiovascular disease management platform)
- RNAvate (research and development of circular RNA therapeutics)
- Cyte Ltd (clinical research)
Category 4: Sponsorship
- Some research and other assistance is provided by an employee of the Thrombosis Research Institute